Overview
Blueprint Prep specializes in online test preparation for high-stakes professional exams. It sells online courses and study materials directly to students preparing for tests such as the MCAT, LSAT, and medical board certifications. Its offerings include personalized study planners, detailed performance analytics, video lessons, and live online instruction. The acquisition of Rosh Review strengthened its medical education portfolio with a robust Qbank and exam products. The company earns revenue through course fees and subscriptions on a direct-to-consumer model. Its target audience includes pre-professional and medical students who seek high-quality, configurable study resources. Unlike others that offer only one format, Blueprint Prep combines multiple learning formats with analytics and a large Qbank to tailor study plans and track progress, aiming to improve test outcomes for its users.
Work here?Claim your company
Simplify's take
What believers are saying
- Blueprint launched an AI-powered MCAT tutor in October 2023 and AI Qbanks in 2026.
- Blueprint and Sketchy announced a 2026 collaboration, expanding distribution and improving MCAT engagement.
- Updated 2026 LSAT and NCLEX content drives urgent student demand for refreshed prep materials.
What critics are saying
- LSAC and NCSBN keep changing exam interfaces and blueprints, forcing constant content rewrites.
- Sketchy and other incumbents intensify MCAT content competition, pressuring Blueprint's differentiation and pricing.
- If acquisition integration fails after Rosh and NP Reviews, its medical expansion strategy stalls.
What makes Blueprint Prep unique
- Blueprint Prep spans MCAT, LSAT, NCLEX, and medical licensure through 2026 acquisitions.
- New Harbor says Rosh Review created a first end-to-end medical education platform in 2026.
- Blueprint combines video lessons, Qbanks, analytics, and campus partnerships across pre-law and pre-med.
Help us improve and share your feedback! Did you find this helpful?